Abundance Wealth Counselors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,887
| Closed | -$1.5M | – | 157 |
|
|
2024
Q4 | $1.5M | Buy |
2,887
+15
| +0.5% | +$7.8K | 0.33% | 51 |
|
|
2024
Q3 | $1.78M | Buy |
+2,872
| New | +$1.78M | 0.37% | 42 |
|
|
2024
Q2 | – | Sell |
-3,131
| Closed | -$1.82M | – | 139 |
|
|
2024
Q1 | $1.82M | Buy |
3,131
+59
| +2% | +$34.3K | 0.42% | 40 |
|
|
2023
Q4 | $1.63M | Buy |
3,072
+10
| +0.3% | +$5.31K | 0.42% | 40 |
|
|
2023
Q3 | $1.55M | Buy |
+3,062
| New | +$1.55M | 0.44% | 36 |
|
|
2023
Q2 | – | Sell |
-3,332
| Closed | -$1.92M | – | 135 |
|
|
2023
Q1 | $1.92M | Sell |
3,332
-155
| -4% | -$89.3K | 0.49% | 30 |
|
|
2022
Q4 | $1.92M | Buy |
3,487
+107
| +3% | +$58.9K | 0.52% | 29 |
|
|
2022
Q3 | $1.71M | Sell |
3,380
-10
| -0.3% | -$5.07K | 0.49% | 26 |
|
|
2022
Q2 | $1.84M | Buy |
3,390
+31
| +0.9% | +$16.8K | 0.5% | 27 |
|
|
2022
Q1 | $1.98M | Buy |
3,359
+362
| +12% | +$214K | 0.54% | 26 |
|
|
2021
Q4 | $2M | Buy |
+2,997
| New | +$2M | 0.51% | 22 |
|
|
2021
Q3 | – | Sell |
-3,074
| Closed | -$1.55M | – | 102 |
|
|
2021
Q2 | $1.55M | Buy |
3,074
+673
| +28% | +$340K | 0.4% | 28 |
|
|
2021
Q1 | $1.1M | Buy |
2,401
+71
| +3% | +$32.4K | 0.27% | 35 |
|
|
2020
Q4 | $1.09M | Sell |
2,330
-51
| -2% | -$23.7K | 0.27% | 29 |
|
|
2020
Q3 | $1.05M | Sell |
2,381
-147
| -6% | -$64.9K | 0.3% | 24 |
|
|
2020
Q2 | $916K | Buy |
2,528
+1,659
| +191% | +$601K | 0.28% | 27 |
|
|
2020
Q1 | $246K | Buy |
+869
| New | +$246K | 0.09% | 31 |
|